Find a TenderPast planning noticePreliminary market engagement notice
Published 1 Apr 2025, 12:31 BST

Official UK procurement notice

Supply and Support of Complete Antibody Quantification Testing Systems

Official notice

Authority: NHS Blood and Transplant (Central government)

GoodsAbove thresholdSME suitable
Planned pipeline value£1,200,000pipeline notice, not a live tender
Tender notice expected 3 Nov 2025from the planned procurement notice
Contract term 7 yrsends 11 May 2033 · up to 11 May 2036 with extensions · starts 11 May 2026

What is being bought

Published requirement description

Anti-D and Anti-c Antibody Quantification NHS Blood & Transplant (NHSBT) Red Cell Immunohaematology (RCI) function is seeking to engage with suppliers of red cell antibody quantification methods via an early market engagement exercise. Please note this is not the start of a procurement process; a separate contract notice will be published to cover this requirement. Prior to commencing the formal procurement process, NHSBT would like to consult the market to improve our knowledge of all current offers available, identify further opportunities and potential issues, as well as gauge market interest in the proposed service. This engagement will help shape NHSBT procurement strategy. The RCI laboratories in NHSBT provide a range of reference services to hospitals, focusing on ensuring safe and effective blood transfusions by diagnosing and managing complex issues related to red blood cells. Antibody (anti-D and anti-c) quantification is a vital component of RCI service, predominantly providing service to NHS hospitals. The test results play a crucial role in guiding the clinical management of alloimmunised ANC patients’ by predicting the risk of haemolytic disease of the foetus and newborn and triggering referral to an FMU specialist, In addition, quantification is used to assist in the laboratory differentiation of immune anti-D from passive anti-D Ig This specialised test conducted in 4 of the 7 RCI laboratories (namely Birmingham, Colindale, Liverpool and Newcastle). RCI processes approximately 10,000 tests annually. The test is vital for identifying levels of alloimmune and prophylactic anti-D, as well as alloimmune anti-c in obstetric and other referrals. NHSBT is seeking to engage with suppliers on the market who can provide Antibody Quantification. The requirement is likely to include the following:

  • Quantification of anti-D and anti-c (expressed in IU/mL).
  • Less than 24-hour TAT
  • Quality requirements (such as CE marked) As part of the early market engagement exercise, NHSBT would like to discuss our requirement with suppliers along with a time frame for supply.

CPV: Medical consumables

The lotProcurement structure

single lot · no lot value published
Lot #1PlannedRenewal 7 yrsSME
Contract period: 11 May 2026 – 11 May 2033 (7 yrs) · up to 11 May 2036 with extensions
Delivery: UK, West Midlands, London, South WestEligibility: SME eligible
Extensions: Extension options published

Procedure terms & legal framework

From the official record
Legal basis
UKPGA · 2023/54 Procurement Act 2023
Procurement category
Goods
Notice status
Past planning notice
Procurement threshold
Above threshold (FTS publication)
Regulatory regime
Standard
Commercial structure
Stand-alone contract (no framework)
Competition type
Competitive procedure
GPA / WTO covered
Unspecified in notice
Recurring procurement
Unspecified in notice
First published
1 Apr 2025, 12:31 BST
Last source update
1 Apr 2025, 12:31 BST
Authority reference
C350958
FTS notice number
2025/S 000-012221
Latest notice
Preliminary market engagement notice (UK2)
Classification (CPV)
Medical consumables
Delivery area
UKWest Midlands (UKG31)London (UKI)South West (UKK11)
Official registry OCID
ocds-h6vhtk-04fb3d Find a Tender

How it was run

Official notice
Submission deadline
—

Timeline

1 Apr 2025 → 11 May 2026 · 4 dates
  1. Planning notice published
    1 Apr 2025, 12:31 BST
  2. Market engagement
    21 May 2025, 23:59 BST

    It is our intention to hold the early market engagement exercise supplier meetings the week of 19th May 2025. The meetings will be held remotely. To enable us to finalise arrangements (e.g. send meeting details and agree time slots), interested organisations are required to send an expression of interest via email to coco.otiotio@nhsbt.nhs.uk by no later than 17:00 hrs (GMT) on Friday 2nd May. This should include a list of your requested attendees and a brief overview (or a website link) of the Goods / Services which might be of interest to us in relation to this requirement. Please include options, if available, for a managed service contract. There is no guarantee that a formal procurement process will be launched as a result of this early market engagement exercise, nor that any contract(s) will be placed. No remuneration or compensation etc will be paid to organisations who take part in this early market engagement exercise. Suppliers should take part in this process only on the basis that they fully understand and accept this position.

  3. Tender notice expected359 days ago
    3 Nov 2025, 23:59 GMT
  4. Contract starts171 days ago
    11 May 2026, 00:00 BST

Notice history

1 event · 1 release on Find a Tender
  1. Preliminary market engagement notice published
    1 Apr 2025, 12:31 BST
    UK2

Commercial outcome & contract awards

Pipeline notice
Awards (0)
No award published
Contracts (0)
No contract published
Bid statistics
No aggregate bid statistics published

Contracting authority & participating public bodies

NHS Blood and Transplant

Contracting authorityPublic authority - central government GB-PPON: PDBY-6395-VWBP 500 North Bristol Park, Bristol, South West, BS34 7QHContact name, email, phone

Official documents & specifications (1)

Official links; attachments are not copied

Notices published for this procedure